Innovation & Research
Monday, October 22, 2018
The National Science Foundation recently awarded a team led by engineer Heng Huang $1.18 million to use machine learning to predict postoperative complications and patient outcomes.
Friday, October 19, 2018
Stiff arteries could lead to “silent” brain damage and therefore dementia risk, a 15-year study led by researchers at Pitt Public Health found. And that risk factor could be preventable.
Wednesday, October 17, 2018
Pitt's Charles Jonassaint led a team that developed the Painimation tablet-based app. The innovation helps patients visually describe where, how much and what kind of pain they feel.
Monday, October 15, 2018
A team led by Pitt engineer Piervincenzo Rizzo is developing a sensor aimed at preventing corrosion-induced pipeline breaks. The technology could have other impacts, including measuring eye pressure in glaucoma patients.
Friday, October 12, 2018
Ann Donnelly, a research specialist in the Department of Biomedical Informatics, was part of a team that created the first-ever artificial enzyme capable of working in a living organism.
Monday, October 8, 2018
As new clinical director of the Aging Institute of UPMC, Anne Newman hopes to figure out why her fellow baby boomers are staying healthier for longer than past generations.
Friday, October 5, 2018
For centuries, people have speculated about the mind-body connection: Does one really affect the other? Neurobiologist Peter Strick’s research on brain pathways may hold answers.
Friday, September 28, 2018
When the Merck Inpatient Unit opened its doors in 1974, it was the only specialized inpatient unit for people with autism in the United States. More than 40 years later, it continues to help affected individuals throughout their lives.
Monday, September 17, 2018
Computers don’t operate like humans when solving complex problems. But Pitt researchers are asking, “What if they could?”
Wednesday, September 12, 2018
At Pitt’s Corneal Cell Biology Lab, researchers have developed an innovative way to address a common form of blindness — by converting stem cells to regrow part of the eye.